Sign In
Buy RHHBY
$51.57
+2.51 (+5.12%)
At Close: Jun 04, 2026
This Risky Micro-Cap Could Pay Off Big
08:31am, Wednesday, 30'th Jun 2021
Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.
Novartis fights Roche in $210 million U.S. dispute over licensing fees
09:57am, Tuesday, 29'th Jun 2021
Novartis wants Roche to return $210 million after accusing its Swiss rival of inappropriately pocketing fees from a 16-year-old patent licensing agreement, according to a U.S. District Court lawsuit.
Top investment strategist David Roche warns the Fed could burst a market 'bubble'
12:13am, Tuesday, 29'th Jun 2021
As the S&P 500 notches record highs, veteran investor David Roche says investors should be wary of the bubble bursting.
Roche's (RHHBY) Actemra Gets FDA Emergency Nod for COVID-19
12:47pm, Monday, 28'th Jun 2021
The FDA issues an Emergency Use Authorization for Roche's (RHHBY) Actemra for the treatment of COVID-19 in hospitalized adults and pediatric patients.
Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder
08:30am, Monday, 28'th Jun 2021
The European Commission has approved Roche Holding AG's (OTC: RHHBY) injectable Enspryng for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD). The approval for the treatme
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG® (satralizumab) for the treatment of adults and adolescents from 12 ye
Roche's arthritis drug gets authorized as COVID-19 treatment for the severely ill
08:30am, Friday, 25'th Jun 2021
Shares of Roche Holding Group were up 0.1% in trading on Friday, the day after the company said its COVID-19 drug has been authorized in the U.S. as a treatment for those who have been hospitalized wi
FDA Gives Emergency Use Nod For Roche's Arthritis Drug Against Severe COVID-19
08:19am, Friday, 25'th Jun 2021
The FDA has approved Roche Holding AG's (OTC:RHHBY) arthritis drug Actemra (tocilizumab) for emergency use to treat adults and pediatric patients hospitalized with COVID-19. It was already allowed
Basel, 25 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActe
Genentech's Actemra Receives FDA Emergency Use Authorization for the Treatment of COVID-19 In Hospitalized Adults and Children
07:15pm, Thursday, 24'th Jun 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has issued an Emerge
Roche's (RHHBY) BLA for PDS With Ranibizumab Accepted by FDA
01:32pm, Thursday, 24'th Jun 2021
The FDA accepts and grants Priority Review to Roche's (RHHBY) application for Port Delivery System with ranibizumab for the treatment of nAMD.
Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA), under Priorit
Alzheimer's Approval Validates Biopharmaceutical Innovation
06:49am, Sunday, 20'th Jun 2021
FDA approval of Biogen's Aduhelm for Alzheimer's should be broadly supportive of biotechnology and pharmaceutical stocks as it signals the agency is willing to be flexible to make important drugs. The
Roche's New COVID-19 Point Of Care Test Scores FDA Emergency Use Nod
01:27pm, Friday, 18'th Jun 2021
The FDA has granted Emergency Use Authorization (EUA) to Roche Holding AG's (OTC: RHHBY) Cobas SARS-CoV-2 Nucleic acid test for use on the Cobas Liat System. This singleplex test is the first real
BASEL, Switzerland, June 18, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for
